Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Investments

Latest From Investments

Bactana secures significant portion of new equity round

US microbiome discovery firm Bactana Animal Health has received $400,000 in financing from Connecticut Innovations.

Investments Pharmaceuticals

Avivagen to further push commercialization efforts with extra funding

Canadian company Avivagen has sourced Can$800,000 ($626,000) from the credit facility provided by Bloom Burton Healthcare Lending Trust.

Feed & Additives Pharmaceuticals

Biovet invests in expanding facilities, diagnostics capabilities

Canadian veterinary diagnostics company Biovet has begun a Can$2.25 million ($1.75 million) expansion of its headquarters, with construction expected to be completed in July.

North America Canada

TyraTech sales climbing as company goes animal health-only

US parasite control company TyraTech has made progress in ramping up its product sales after it decided to focus solely on animal health.

North America United States

MBFT gains funding to support canine melanoma vaccine

US firm Man's Best Friend Therapeutics (MBFT) has receive $250,000 in funding from Benjamin Franklin Technology Partners.

Vaccines Canine

Heska welcomes Schein joint venture with Vets First Choice

The upcoming merger between leading veterinary distributor Henry Schein and Vets First Choice to create a diagnostics subsidiary has been welcomed by rival firm Heska.

North America United States
See All